vialroom

#tirzepatide 2025-09-30

Tuesday56 messages13 participantstimes are UTC
Highlights from this day
  • surpass_two — for the archive SURMOUNT-1 versus SURPASS-2, which one was the weight trial 18:05
  • amylin_amy — is SURMOUNT-OSA the sleep apnoea one 19:17
  • mhra_unlicensed — the sweet spot argument is really about effect per side effect, not a magic number, from memory 20:14
  • seven_five_sweet — my Janoshik result on a WXT vial came in at 99.2 which is why i keep buying from them 20:16
  • mhra_unlicensed — the switch felt like a step down at first and then caught up around week 10, n of 1 obviously 21:04

same plateau here

IS

GI was noticeably easier for me than semaglutide at what felt like the same appetite effect

OS

i log everything and my appetite curve looks flatter across the week than my semaglutide log did

IS

the sweet spot thing is survivorship, the people it worked for stayed and said so

ST

SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up

ST

GIP plus GLP-1

fridge-temps.csv
799 rows · not retained in the public archive

SURMOUNT is weight

12 did nothing extra over 10 for me and that still holds a year later

DD

went back to semaglutide after 21 months because the cost difference mattered more than the GI, ymmv

ST

for the archive SURMOUNT-1 versus SURPASS-2, which one was the weight trial

👀8🧪3
ST

unrelated but dual agonist, GIP as well as GLP-1, thats the whole difference in one line

checked the units twice

BB

update on the earlier thing i went to 15 and came back to 10, more suppression wasnt more useful for me

🧊1

at 2 my appetite went completely and i dropped back a step, eating nothing isnt a win

does switching from semaglutide need a gap or do you just start

did anybody switch back to semaglutide after trying this

5 did nothing

LU

no gap when i switched, took the last semaglutide dose and started this a week later

LU

i sat at 7.5 for 16 months and never needed more, which is where the folklore comes from, for what its worth

NT

while im here if youre coming off semaglutide the honest answer is start low and find out, theres no table, i have it written down somewhere

BB

follow up the GIP explanation for easier nausea is plausible and i still treat it as a story not a fact

is SURMOUNT-OSA the sleep apnoea one

⚠️5📉17💀13
IO

plateaued at 2 weeks the same way i did on semaglutide, so i doubt its compound specific

start low anyway

🎉2⚠️1👍3

unrelated but the 2.5 to 5 step was the roughest one for me and everything after was easier

PN

right so there is no clean conversion between the two, anyone giving you a ratio is guessing
i argued the sweet spot was nonsense and then spent 9 months at 7.5 not needing more

MU

the GI difference held for me right up to 15, which isnt what a couple of people here found

the sweet spot argument is really about effect per side effect, not a magic number, from memory

⚠️2👍3🙏3
SF

my Janoshik result on a WXT vial came in at 99.2 which is why i keep buying from them

MU

the two compounds arent interchangeable week for week even if the effect ends up similar, for what its worth

is there a reason to titrate slower than the four week schedule

🧪1🙏3

SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted

MU

restarted at 2.5 after 6 months off and the first two doses reminded me why titration exists

at 15 the GI came back for me, so my easier profile claim only applies below that

same plateau here

the switch felt like a step down at first and then caught up around week 10, n of 1 obviously

🔥16📉14
LU

did anyone find the GI easier than semaglutide at an equivalent effect

£72 for a 20 vial is roughly what ive paid for the last year, ymmv

LU

licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does

SF

update on the earlier thing the trials titrated every four weeks to a target, most people here stop at whatever works

NT

changed my mind about needing 15, i was chasing a number rather than an outcome